|
1
|
El-Serag HB and Rudolph KL: Hepato
cellular carcinoma: Epidemiology and molecular carcinogenesis.
Gastroenterology. 132:2557–2576. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kew MC: Epidemiology of chronic hepatitis
B virus infection, hepatocellular carcinoma, and hepatitis B
virus-induced hepatocellular carcinoma. Pathol Biol (Paris).
58:273–277. 2010. View Article : Google Scholar
|
|
3
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pedroza-Gonzalez A, Verhoef C, Ijzer mans
JN, Peppelenbosch MF, Kwekkeboom J, Verheij J, Janssen HL and
Sprengers D: Activated tumor-infiltrating CD4+
regulatory T cells restrain antitumor immunityin patients with
primary or metastatic liver cancer. Hepatology. 57:183–194. 2013.
View Article : Google Scholar
|
|
5
|
Yang ZQ, Yang ZY, Zhang LD, Ping-Bie, Wang
SG, Ma KS, Li XW and Dong JH: Increased liver-infiltrating
CD8+ Foxp3+ regulatory T cells are associated
with tumor stage in hepato-cellular carcinoma patients. Hum
Immunol. 71:1180–1186. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yi Y and He HW: The functional impairment
of HCC-infiltrating γδ T cells, partially mediated by regulatory T
cells in a TGFβ-and IL-10-dependent manner. J Hepatol. 58:977–983.
2013. View Article : Google Scholar
|
|
7
|
Han KH and Kudo M: Asian consensus
workshop report: Expert consensus guideline for the management of
intermediate and advanced hepatocellular carcinoma in Asia.
Oncology. 81(Suppl 1): 158–164. 2011. View Article : Google Scholar
|
|
8
|
Smith JA, Francis TI, Edington GM and
Williams AO: Immunofluorescent localisation of human alpha
feto-protein in fetal and neonatal livers and cultured cells from
hepatocellular carcinoma. Br J Cancer. 25:343–349. 1971. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Heger N, Bayindir S, Steckenmesser R and
Schirmer H: Percutaneous catheter-arteriographies: Seldinger
technique. Minn Med. 53:1093–1097. 1970.PubMed/NCBI
|
|
10
|
Motola-Kuba D, Zamora-Valdés D, Uribe M
and Méndez-Sánchez N: Hepatocellular carcinoma. An overview. Ann
Hepatol. 5:16–24. 2006.PubMed/NCBI
|
|
11
|
Horiguchi S, Petersson M, Nakazawa T,
Kanda M, Zea AH, Ochoa AC and Kiessling R: Primary chemically
induced tumors induce profound immunosuppression concomitant with
apoptosis and alterations in signal transduction in T cells and NK
cells. Cancer Res. 59:2950–2956. 1999.PubMed/NCBI
|
|
12
|
Sakaguchi S, Yamaguchi T, Nomura T and Ono
M: Regulatory T cells and immune tolerance. Cell. 133:775–787.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ke X, Wang J, Li L, Chen IH, Wang H and
Yang XF: Roles of CD4+ CD25 (high) FOXP3+
Tregs in lymphomas and tumors are complex. Front Biosci.
13:3986–4001. 2008.PubMed/NCBI
|
|
14
|
Wing K and Sakaguchi S: Regulatory T cells
exert checks and balances on self tolerance and autoimmunity. Nat
Immunol. 11:7–13. 2010. View
Article : Google Scholar
|
|
15
|
Jiang S and Lechler RI: CD4+
CD25+ regulatory T-cell therapy for allergy, autoimmune
disease and transplant rejection. Inflamm Allergy Drug Targets.
5:239–242. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Fu J, Xu D, Liu Z, Shi M, et al: Increased
regulatory T cells correlate with CD8 T-cell impairment and poor
survival in hepatocellular carcinoma patients. Gastroenterology.
132:2328–2339. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ghiringhelli F, Ménard C, Terme M, et al:
CD4+ CD25+ regulatory T cells inhibit natural
killer cell functions in a transforming growth
factor-beta-dependent manner. J Exp Med. 202:1075–1085. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Pandiyan P, Zheng L, Ishihara S, Reed J
and Lenardo MJ: CD4+ CD25+Foxp3+
regulatory T cells induce cytokine deprivation-mediated apoptosis
of effector CD4+ T cells. Nat Immunol. 8:1353–1362.
2007. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ormandy LA, Hillemann T, Wedemeyer H,
Manns MP, Greten TF and Korangy F: Increased populations of
regulatory T cells in peripheral blood of patients with
hepatocellular carcinoma. Cancer Res. 65:2457–2464. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yang XH, Yamagiwa S, Ichida T, et al:
Increase of CD4+ CD25+ regulatory T-cells in
the liver of patients with hepatocellular carcinoma. J Hepatol.
45:254–262. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Shen X, Li N, Li H, Zhang T, Wang F and Li
Q: Increased prevalence of regulatory T cells in the tumor
microenvironment and its correlation with TNM stage of
hepatocellular carcinoma. J Cancer Res Clin Oncol. 136:1745–1754.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhou J, Ding T, Pan W, Zhu LY, Li L and
Zheng L: Increased intratumoral regulatory T cells are related to
intratumoral macrophages and poor prognosis in hepatocellular
carcinoma patients. Int J Cancer. 125:1640–1648. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hoechst B, Ormandy LA, Ballmaier M, et al:
A new population of myeloid-derived suppressor cells in
hepatocellular carcinoma patients induces CD4(+) CD25(+) Foxp3(+) T
cells. Gastroenterology. 135:234–243. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yoshizawa K, Abe H, Kubo Y, et al:
Expansion of CD4(+)CD25(+) FoxP3(+) regulatory T cells in hepatitis
C virus-related chronic hepatitis, cirrhosis and hepatocellular
carcinoma. Hepatol Res. 40:179–187. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Cai L, Zhang Z, Zhou L, et al: Functional
impairment in circulating and intrahepatic NK cells and relative
mechanism in hepatocellular carcinoma patients. Clin Immunol.
129:428–437. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Unitt E, Rushbrook SM, Marshall A, et al:
Compromised lymphocytes infiltrate hepatocellular carcinoma: the
role of T-regulatory cells. Hepatology. 41:722–730. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang HH, Mei MH, Fei R, et al: The
frequency, phenotypes and functions of CD4+
CD25+ regulatory T cells in hepatocellular carcinoma
patients. Zhonghua Gan Zang Bing Za Zhi. 15:266–272. 2007.In
Chinese. PubMed/NCBI
|
|
28
|
Collison LW, Workman CJ, Kuo TT, Boyd K,
et al: The inhibitory cytokine IL-35 contributes to regulatory
T-cell function. Nature. 450:566–569. 2007. View Article : Google Scholar : PubMed/NCBI
|
